{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:39:14Z","timestamp":1789749554052,"version":"4.0.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.wneu.2019.05.157","type":"journal-article","created":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T21:08:44Z","timestamp":1558732124000},"page":"e387-e392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Symptomatic Cavernous Malformation Presenting with Seizure without Hemorrhage: Analysis of Factors Influencing Clinical Presentation"],"prefix":"10.1016","volume":"129","author":[{"given":"Edoardo","family":"Agosti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly D.","family":"Flemming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1479-465X","authenticated-orcid":false,"given":"Giuseppe","family":"Lanzino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2019.05.157_bib1","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1111\/epi.12402","article-title":"Cavernoma-related epilepsy: review and recommendations for management\u2013report of the Surgical Task Force of the ILAE Commission on Therapeutic Strategies","volume":"54","author":"Rosenow","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.wneu.2019.05.157_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1474-4422(12)70004-2","article-title":"Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study","volume":"11","author":"Al-Shahi Salman","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.wneu.2019.05.157_bib3","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1212\/WNL.0b013e318248de9b","article-title":"Prospective hemorrhage risk of intracerebral cavernous malformations","volume":"78","author":"Flemming","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.wneu.2019.05.157_bib4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1474-4422(15)00303-8","article-title":"Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data","volume":"15","author":"Horne","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.wneu.2019.05.157_bib5","first-page":"820","article-title":"The natural history of cerebral cavernous malformations","volume":"83","author":"Kondziolka","year":"1995","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2019.05.157_bib6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s002340050893","article-title":"The natural history of familial cerebral cavernomas: a retrospective MRI study of 40 patients","volume":"42","author":"Labauge","year":"2000","journal-title":"Neuroradiology"},{"key":"10.1016\/j.wneu.2019.05.157_bib7","first-page":"190","article-title":"Cerebral cavernous malformations: natural history and prognosis after clinical deterioration with or without hemorrhage","volume":"87","author":"Porter","year":"1997","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2019.05.157_bib8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJM198808113190605","article-title":"Cerebral cavernous malformations. Incidence and familial occurrence","volume":"319","author":"Rigamonti","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2019.05.157_bib9","first-page":"709","article-title":"Natural history of the cavernous angioma","volume":"75","author":"Robinson","year":"1991","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2019.05.157_bib10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/CIRCULATIONAHA.114.010403","article-title":"Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation","volume":"131","author":"Gibson","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.wneu.2019.05.157_bib11","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1161\/STROKEAHA.118.024058","article-title":"Rho kinase inhibition blunts lesion development and hemorrhage in murine models of aggressive Pdcd10\/Ccm3 disease","volume":"50","author":"Shenkar","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2019.05.157_bib12","first-page":"1","article-title":"Antithrombotic medication and bleeding risk in patients with cerebral cavernous malformations: a cohort study","author":"Bervini","year":"2018","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2019.05.157_bib13","first-page":"43","article-title":"Use of antithrombotic agents in patients with intracerebral cavernous malformations","volume":"118","author":"Flemming","year":"2013","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2019.05.157_bib14","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1161\/STROKEAHA.112.668533","article-title":"Antithrombotic therapy and bleeding risk in a prospective cohort study of patients with cerebral cavernous malformations","volume":"43","author":"Schneble","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2019.05.157_bib15","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1161\/STROKEAHA.108.515544","article-title":"Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Angioma Alliance Scientific Advisory Board","volume":"39","author":"Al-Shahi Salman","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2019.05.157_bib16","first-page":"422","article-title":"The natural history of familial cavernous malformations: results of an ongoing study","volume":"80","author":"Zabramski","year":"1994","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2019.05.157_bib17","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1227\/NEU.0b013e3181eb5032","article-title":"Epileptogenicity of cavernomas depends on (archi-) cortical localization","volume":"67","author":"Menzler","year":"2010","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2019.05.157_bib18","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.02.025","article-title":"Infratentorial developmental venous abnormalities and inflammation increase odds of sporadic cavernous malformation","volume":"28","author":"Kumar","year":"2019","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.wneu.2019.05.157_bib19","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.biocel.2016.09.011","article-title":"Oxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: two sides of the same coin","volume":"81","author":"Retta","year":"2016","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.wneu.2019.05.157_bib20","first-page":"429","article-title":"Emerging pharmacologic targets in cerebral cavernous malformation and potential strategies to alter the natural history of a difficult disease: a review","volume":"4","author":"Chohan","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.wneu.2019.05.157_bib21","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/neuros\/nyy108","article-title":"Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) trial","volume":"84","author":"Polster","year":"2019","journal-title":"Neurosurgery"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875019314342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875019314342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:29:59Z","timestamp":1761812999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875019314342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":21,"alternative-id":["S1878875019314342"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2019.05.157","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Symptomatic Cavernous Malformation Presenting with Seizure without Hemorrhage: Analysis of Factors Influencing Clinical Presentation","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2019.05.157","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}